Publication: Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model
| dc.contributor.author | Tripanichkul W. | |
| dc.contributor.author | Jaroensuppaperch E.-O. | |
| dc.date.accessioned | 2021-04-05T03:34:18Z | |
| dc.date.available | 2021-04-05T03:34:18Z | |
| dc.date.issued | 2012 | |
| dc.date.issuedBE | 2555 | |
| dc.description.abstract | This study investigated the effects of curcumin on nigrostriatal dopaminergic (DA) neurons and glial response in 6-hydroxydopamine (6-OHDA) hemiparkinsonian mice. Following unilateral intrastriatal 6-OHDA injection, mice were daily injected with curcumin for seven days, beginning on the day of lesion. Seven days after 6-OHDA lesioning, sections from the striatum and the substantia nigra pars compacta (SNpc) were collected and immunohistochemically stained for DA neurons and reactive glia. Curcumin decreased 6-OHDA-induced loss of nigral tyrosine hydroxylase-immunoreactive (TH-IR) neurons and striatal TH-IR fibers. The neuroprotection was coincided with a significant attenuation of microglial and astroglial reaction in the SNpc and the striatum. These results suggest that the neuroprotective effects of curcumin in 6-OHDA-lesioned mice may be mediated through its anti-inflammatory properties or direct protection on nigral DA neurons, thereby reducing neuronal injury-induced glial activation. © 2011 Informa Healthcare USA, Inc. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | International Journal of Neuroscience. Vol 122, No.5 (2012), p.263-270 | |
| dc.identifier.doi | 10.3109/00207454.2011.648760 | |
| dc.identifier.issn | 207454 | |
| dc.identifier.other | 2-s2.0-84859395842 | |
| dc.identifier.uri | https://swu-dspace2.eval.plus/handle/123456789/7067 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | Curcumin | |
| dc.subject.other | Oxidopamine | |
| dc.subject.other | Tyrosine 3 monooxygenase | |
| dc.subject.other | Animal experiment | |
| dc.subject.other | Animal model | |
| dc.subject.other | Animal tissue | |
| dc.subject.other | Article | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Corpus striatum | |
| dc.subject.other | Dopaminergic nerve cell | |
| dc.subject.other | Glia | |
| dc.subject.other | Immunohistochemistry | |
| dc.subject.other | Immunoreactivity | |
| dc.subject.other | Macroglia | |
| dc.subject.other | Male | |
| dc.subject.other | Mouse | |
| dc.subject.other | Neuroprotection | |
| dc.subject.other | Nigroneostriatal system | |
| dc.subject.other | Nonhuman | |
| dc.subject.other | Parkinsonism | |
| dc.subject.other | Substantia nigra | |
| dc.subject.other | Animals | |
| dc.subject.other | Corpus Striatum | |
| dc.subject.other | Curcumin | |
| dc.subject.other | Disease Models, Animal | |
| dc.subject.other | Dopaminergic Neurons | |
| dc.subject.other | Male | |
| dc.subject.other | Mice | |
| dc.subject.other | Mice, Inbred ICR | |
| dc.subject.other | Neural Pathways | |
| dc.subject.other | Neuroglia | |
| dc.subject.other | Parkinsonian Disorders | |
| dc.subject.other | Substantia Nigra | |
| dc.subject.other | Treatment Outcome | |
| dc.title | Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859395842&doi=10.3109%2f00207454.2011.648760&partnerID=40&md5=b3358bf5ed86d31414dd84758be0e724 |